• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News

cafead

Administrator
Staff member
  • cafead   Jan 17, 2024 at 10:12: AM
via There has been another twist in the road for the ongoing legal battle between Seagen and Daiichi Sankyo over patent rights for antibody-drug conjugate (ADC) Enhertu.

article source
 

<